Zimmer Biomet Holdings, Inc. (ZBH)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 108.53 |
| Open | 107.01 |
| Bid | 104.00 x 900 |
| Ask | 137.20 x 1400 |
| Day's range | 105.82 - 108.90 |
| 52-week range | 102.00 - 144.13 |
| Volume | |
| Avg. volume | 1,477,251 |
| Market cap | 21.799B |
| Beta (5Y monthly) | 1.02 |
| PE ratio (TTM) | 22.98 |
| EPS (TTM) | 4.61 |
| Earnings date | 30 July 2024 - 05 Aug 2024 |
| Forward dividend & yield | 0.96 (0.91%) |
| Ex-dividend date | 26 June 2024 |
| 1y target est | 136.44 |
Simply Wall St.Here's What We Like About Zimmer Biomet Holdings' (NYSE:ZBH) Upcoming Dividend
Zimmer Biomet Holdings, Inc. ( NYSE:ZBH ) is about to trade ex-dividend in the next 3 days. The ex-dividend date is one...
Zacks3 Generative AI-Based MedTech Stocks to Keep an Eye On
With the growing influence of GenAI in the MedTech sector, innovators like ZBH, GEHC and MDT are poised to thrive.
PR NewswireZimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Devdatt "Dev" Kurdikar, President, Chief Executive Officer and a member of the board of directors of Embecta Corp. (embecta), has been appointed to the Zimmer Biomet Board, effective immediately. embecta (Nasdaq: EMBC), formerly part of Becton, Dickinson and Company (BD), is one of the largest pure-play diabetes management companies in the world.
© 2024 Yahoo. All rights reserved.